State Lawmakers Call For FTC To Probe CVS Caremark

Law360, New York (May 7, 2009, 12:00 AM EDT) -- A group of state lawmakers has asked the Federal Trade Commission to investigate whether the 2007 merger that created CVS Caremark Corp. has led to fraudulent and anti-competitive conduct, hurting prescription drug consumers.

Sharon Anglin Treat, executive director of the National Legislative Association on Prescription Drug Prices, said in a letter to FTC Chairman Jon Leibowitz on Thursday that the combination of CVS, a pharmacy operator, and Caremark, a pharmacy benefit manager, created opportunities for the company to enrich itself at the expense of competition and...
To view the full article, register now.